US2002004588A1PendingUtilityA1
Monoazo metal complex compound containing composition and production method thereof
Priority: May 31, 2000Filed: May 31, 2001Published: Jan 10, 2002
Est. expiryMay 31, 2020(expired)· nominal 20-yr term from priority
C09B 45/01C09B 45/14G03G 9/091G03G 9/09783C09B 67/0096
37
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Monoazo metal complex compound containing composition, the incidence of skin sensitization in a skin sensitization potential test based on the maximization method of said composition being not more than 20% and method for producing said composition which comprises a step for removing impurity substances using an alcoholic organic solvent; charge control agent comprising said composition and toner containing said charge control agent; coloring agent containing said composition and colored thermoplastic resin composition containing said coloring agent.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . Monoazo metal complex compound containing composition, the incidence of skin sensitization in a skin sensitization potential test of said composition being not more than 20%.
2 . Monoazo metal complex compound containing composition of claim 1 wherein said skin sensitization potential test is a skin sensitization potential test based on the maximization method.
3 . Monoazo metal complex compound containing composition of claim 1 wherein the purity of said monoazo metal complex compound is not less than 90% as determined by high performance liquid chromatography.
4 . Monoazo metal complex compound containing composition of claim 2 wherein the purity of said monoazo metal complex compound is not less than 90% as determined by high performance liquid chromatography.
5 . Monoazo metal complex compound containing composition of any of claims 1 , 2 , 3 or 4 wherein said monoazo metal complex compound is a compound of the following formula (1):
wherein each of R 1 through R 4 and R 6 independently represents a hydrogen atom, a normal or branched alkyl group having 1 to 18 carbon atoms, a normal or branched alkenyl group having 2 to 18 carbon atoms, a sulfonamide group, a mesyl group, a sulfonic acid group, a hydroxy group, an alkoxy group having 1 to 18 carbon atoms, an acetylamino group, a benzoylamino group, a halogen atom, or —COO—R 7 ;
R 7 represents a normal or branched alkyl group having 1 to 18 carbon atoms or an aryl group having 6 to 18 carbon atoms;
R 5 represents a hydrogen atom, a halogen atom, a nitro group, a carboxyl group, a normal or branched alkyl group having 1 to 18 carbon atoms, an alkenyl group having 2 to 18 carbon atoms, an alkoxy group having 1 to 18 carbon atoms, an aryl group having 6 to 18 carbon atoms, —COO—R 8 or
R 8 represents a normal or branched alkyl group having 1 to 18 carbon atoms or an aryl group having 6 to 18 carbon atoms;
Y represents a hydrogen atom, a normal or branched alkyl group having 1 to 8 carbon atoms, an alkoxy group having 1 to 5 carbon atoms, a nitro group, or a halogen atom;
m represents an integer from 1 to 3;
M represents a divalent or trivalent metal;
p represents 1 or 2;
(A) q+ represents H + , NH 4 + , a cation based on an alkali metal, a cation based on an organic amine, or a quaternary organic ammonium ion;
q represents 1 or 2; and
X represents 1 or 2.
6 . Monoazo metal complex compound containing composition of claim 5 wherein R 2 in Formula (1) above is Cl;
each of R 1 and R 3 through R 5 is a hydrogen atom;
R 6 is a hydrogen atom or a normal or branched alkyl group having 1 to 18 carbon atoms;
M is Cr, Fe, or Cu; and
(A) q+ is H + .
7 . Method for producing a monoazo metal complex compound containing composition which comprises a step for removing impurity substances using an alcoholic organic solvent, the incidence of skin sensitization in a skin sensitization potential test of said composition being not more than 20%.
8 . Method for producing the monoazo metal complex compound containing composition of claim 7 wherein said skin sensitization potential test is a skin sensitization potential test based on the maximization method.
9 . Method for producing the monoazo metal complex compound containing composition of claim 7 wherein the purity of said monoazo metal complex compound is not less than 90% as determined by high performance liquid chromatography.
10 . Method for producing the monoazo metal complex compound containing composition of claim 8 wherein the purity of said monoazo metal complex compound is not less than 90% as determined by high performance liquid chromatography.
11 . Method for producing the monoazo metal complex compound containing composition of claim 7 , 8 , 9 or 10 wherein said alcoholic organic solvent is one member or a mixture of two or more members selected from the group consisting of methanol, ethanol, 1-propanol, 2-propanol, n-butanol, ethylene glycol, propylene glycol monomethyl ether and ethylene glycol monoethyl ether.
12 . Method for producing a monoazo metal complex compound containing composition which comprises a step for synthesizing a monoazo metal complex compound in an alcoholic organic solvent, and a step for removing impurity substances from the product of the synthetic step using an alcoholic organic solvent, the incidence of skin sensitization in a skin sensitization potential test of said composition being not more than 20%.
13 . Method for producing the monoazo metal complex compound containing composition of claims 12 wherein said skin sensitization potential test is a skin sensitization potential test based on the maximization method.
14 . Method for producing the monoazo metal complex compound containing composition of claims 12 wherein the purity of said monoazo metal complex compound is not less than 90% as determined by high performance liquid chromatography.
15 . Method for producing the monoazo metal complex compound containing composition of claims 13 wherein the purity of said monoazo metal complex compound is not less than 90% as determined by high performance liquid chromatography.
16 . Method for producing the monoazo metal complex compound containing composition of claim 12 , 13 , 14 or 15 wherein said alcoholic organic solvent is one member or a mixture of two or more members selected from the group consisting of methanol, ethanol, 1-propanol, 2-propanol, n-butanol, ethylene glycol, propylene glycol monomethyl ether and ethylene glycol monoethyl ether.
17 . Method for producing a monoazo metal complex compound containing composition which comprises a step for synthesizing a monoazo metal complex compound in an alcoholic organic solvent, and a step for removing impurity substances by directly filtering a reaction mixture containing the product obtained by the synthetic step, the incidence of skin sensitization in a skin sensitization potential test of said composition being not more than 20%.
18 . Method for producing the monoazo metal complex compound containing composition of claims 17 wherein said skin sensitization potential test is a skin sensitization potential test based on the maximization method.
19 . Method for producing the monoazo metal complex compound containing composition of claims 18 wherein the purity of said monoazo metal complex compound is not less than 90% as determined by high performance liquid chromatography.
20 . Method for producing the monoazo metal complex compound containing composition of claims 19 wherein the purity of said monoazo metal complex compound is not less than 90% as determined by high performance liquid chromatography.
21 . Method for producing the monoazo metal complex compound containing composition of claim 17 , 18 , 19 or 20 wherein said alcoholic organic solvent is one member or a mixture of two or more members selected from the group consisting of methanol, ethanol, 1-propanol, 2-propanol, n-butanol, ethylene glycol, propylene glycol monomethyl ether and ethylene glycol monoethyl ether.
22 . Charge control agent comprising a monoazo metal complex compound containing composition, the incidence of skin sensitization in a skin sensitization potential test of said composition being not more than 20%.
23 . Toner for developing electrostatic images which contains a charge control agent comprising a monoazo metal complex compound containing composition, the incidence of skin sensitization in a skin sensitization potential test of said composition being not more than 20%.
24 . Coloring agent containing the monoazo metal complex compound containing composition, the incidence of skin sensitization in a skin sensitization potential test of said composition being not more than 20%.
25 . Colored thermoplastic resin composition containing the monoazo metal complex compound containing composition as a coloring agent, the incidence of skin sensitization in a skin sensitization potential test of said composition being not more than 20%.Join the waitlist — get patent alerts
Track US2002004588A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.